GENERIC NAME OF THE MEDICINAL PRODUCT:

A. Molnupiravir Capsules 200mg
B. Molnupiravir Capsules 400mg

QUALITATIVE AND QUANTITATIVE COMPOSITION:

A. Molnupiravir Capsules 200mg
Composition:
Each Hard gelatin capsule contains:
Molnupiravir …………………...200mg
Excipients……………………………...Q.S.
Colour used in capsule shell: Titanium dioxide Ph. Eur.

B. Molnupiravir Capsules 400mg
Composition:
Each Hard gelatin capsule contains:
Molnupiravir …………………...400mg
Excipients……………………………...Q.S.
Colour used in capsule shell: Sunset yellow FCF


THERAPEUTIC INDICATIONS:

Molnupiravir is an antiviral medication that inhibits the replication of certain RNA viruses. It is used to treat COVID-19 in those infected by SARS-CoV-2.
This medicine reduces the replication of SARS-CoV-2, and prevents infectious virus with rapid speed.
Molnupiravir drug has broad anti-influenza activity, which includes highly potent inhibition of SARS-CoV-2 replication.

CAUTION & WARNING:

CAUTION: Do not swallow whole or chew.
FOR HOSPITAL ONLY
WARNING: To be sold by retail on the prescription of Registered Medical Practitioner only.
Do not skip/discontinue the dose for effective treatment.
Keep out of reach of children.

STORAGE & DOSAGE:

Storage: Store protected from moisture at a temperature not exceeding 30°C.
Do not refrigerate.
Dosage: As directed by the Physician.
Special Warning: Maintain hygiene, and do not come in contact with infected persons.
Note: Approved for Restricted use in Emergency.

Molnupiravir Capsules 400mg Technical Specification:

Product Name:
Molnupiravir Capsules 400mg
Brand Name:Molnutaj
Strength:200mg, 400mg
Dosage Form:Hard gelatine Capsule
Route of Administration:Via oral Route
Packing:10s Blisters
40 Tab Bottle
Pack Insert/Leaflet:PIL (Patient Information Leaflet), SmPC (Summary Product Characteristics)
Regulatory Documents:COA, MOA, COPP, FSC, Stability Studies, GMP, CTD Dossier
Therapeutic use:Antiviral, COVID-19
Indication: Molnupiravir is an antiviral medication that inhibits the replication of certain RNA viruses. It is used to treat COVID-19 in those infected by SARS-CoV-2. This medicine reduces the replication of SARS-CoV-2, and prevents infectious virus with rapid speed.
Storage:Store protected from moisture at a temperature not exceeding 30°C. Do not refrigerate.

GENERIC NAME OF THE MEDICINAL PRODUCT:

  • Molnupiravir Capsules 400mg

QUALITATIVE AND QUANTITATIVE COMPOSITION:

  • Molnupiravir Capsules 400mg
    Composition:
    Each Hard gelatin capsule contains:
    Molnupiravir ……………………400mg
    Excipients………………………………Q.S.
    Colour used in capsule shell: Sunset yellow FCF

THERAPEUTIC INDICATIONS:

Molnupiravir is an antiviral medication that inhibits the replication of certain RNA viruses. It is used to treat COVID-19 in those infected by SARS-CoV-2.

This medicine reduces the replication of SARS-CoV-2, and prevents infectious virus with rapid speed.

Molnupiravir drug has broad anti-influenza activity, which includes highly potent inhibition of SARS-CoV-2 replication.

CAUTION & WARNING:

CAUTION: Do not swallow whole or chew.

 FOR HOSPITAL ONLY

WARNING: To be sold by retail on the prescription of Registered Medical Practitioner only.

 Do not skip/discontinue the dose for effective treatment.

Keep out of reach of children.

STORAGE & DOSAGE:

Storage: Store protected from moisture at a temperature not exceeding 30°C.
Do not refrigerate.

Dosage:  As directed by the Physician.

Special Warning: Maintain hygiene, and do not come in contact with infected persons.

Note: Approved for Restricted use in Emergency.